Tag archive for ‘Committee for Medicinal Products for Human Use (CHMP)’
Jewish Business News Service On Sunday, January 26th, 2014

Teva and Active Biotech to Continue Laquinimod for Multiple Sclerosis Development Despite EMA

– Europe’s Committee for Medicinal Products for Human Use: The risk-benefit profile of laquinimod is not favorable at this time. –  – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) More...

Wordpress site Developed by Fixing WordPress Problems